United States
US 12,702,709 B2
Methods for treating chronic rhinosinusitis with nasal polyps by administering an antibody antagonist of IL-4R
US 12,702,709 B2 is a granted patent from the United States Patent and Trademark Office (USPTO), dated 2026-08-11. Applicant: Regeneron Pharmaceuticals, Inc.; Sanofi Biotechnology. Its PDF downloads from this page without an account, up to 5 a day.
- Applicant
- Regeneron Pharmaceuticals, Inc.; Sanofi Biotechnology
- Inventors
- Leda Mannent; Gianluca Pirozzi; Brian Swanson; Allen Radin; Namita A. Gandhi; Robert Evans; Jennifer Hamilton
- Publication date
- 2026-08-11
- Filing date
- 2021-11-23
- Document type
- B2 Granted patent
- Also written as
- US 12,702,709 B2 · US12702709 · 12702709
Abstract
The present invention provides methods for decreasing a nasal polyp score in a subject. The methods include administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist such as an anti-IL-4R antibody or antigen binding fragment thereof.
The opening of the abstract. The full text is in the PDF.
No account needed: 5 free downloads a day (5 left today). Batch downloads and Office Action citations need a free account.
Patent office website: United States Patent and Trademark Office (USPTO)
Look up another patent
Need many patents at once?
Paste a whole list of numbers. DownloadPatent finds the right version of each and packs the PDFs into one ZIP.
Sign up free